Circulating biomarkers of pulmonary and extrapulmonary tuberculosis in children

Clinical and Vaccine Immunology

Volumn 20, Issue 5, 2013, Pages 704-711

  Kumar, Nathella Pavan ^a   Anuradha, R ^a   Andrade, Bruno B ^d   Suresh, N ^b   Ganesh, R ^b   Shankar, Janani ^b   Kumaraswami, V ^c   Nutman, Thomas B ^d   Babu, Subash ^a,d  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b KANCHI KAMAKOTI CHILDS TRUST HOSPITAL   (India)

^c NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MICROGLOBULIN; ALPHA INTERFERON; BETA INTERFERON; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GAMMA INTERFERON; HAPTOGLOBIN; HEME OXYGENASE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 20; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LIPOPOLYSACCHARIDE BINDING PROTEIN; MATRILYSIN; NEUTROPHIL COLLAGENASE; PLASMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE MARKER; EXTRAPULMONARY TUBERCULOSIS; FEMALE; FIBROSIS; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOREGULATION; INFANT; INNATE IMMUNITY; LUNG TUBERCULOSIS; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHOOL CHILD;

ACUTE-PHASE PROTEINS; ADOLESCENT; ALPHA-MACROGLOBULINS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CYTOKINES; DISEASE PROGRESSION; FEMALE; FIBROSIS; HAPTOGLOBINS; HUMANS; INFANT; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MATRIX METALLOPROTEINASE INHIBITORS; MATRIX METALLOPROTEINASES; MEMBRANE GLYCOPROTEINS; OXIDATIVE STRESS; TISSUE INHIBITOR OF METALLOPROTEINASES; TUBERCULOSIS;

EID: 84876827144     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00038-13     Document Type: Article

References (51)

1. Perez-Velez CM, Marais BJ. 2012. Tuberculosis in children. N. Engl. J. Med. 367:348-361.
2. Walls T, Shingadia D. 2004. Global epidemiology of paediatric tuberculosis. J. Infect. 48:13-22. (Pubitemid 38072198)
3. Nelson LJ, Wells CD. 2004. Global epidemiology of childhood tuberculosis. Int. J. Tuberc. Lung Dis. 8:636-647. (Pubitemid 38625076)
4. Cotton MF, Schaaf HS, Lottering G, Weber HL, Coetzee J, Nachman S. 2008. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int. J. Tuberc. Lung Dis. 12:225-227. (Pubitemid 351212418)
5. Lawn SD, Bekker LG, Middelkoop K, Myer L, Wood R. 2006. Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions. Clin. Infect. Dis. 42:1040-1047.
6. Swaminathan S, Rekha B. 2010. Pediatric tuberculosis: global overview and challenges. Clin. Infect. Dis. 50(Suppl 3):S184-S194.
7. Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B. 2008. Paediatric tuberculosis. Lancet Infect. Dis. 8:498-510. (Pubitemid 352001412)
8. Cuevas LE, Browning R, Bossuyt P, Casenghi M, Cotton MF, Cruz AT, Dodd LE, Drobniewski F, Gale M, Graham SM, Grzemska M, Heinrich N, Hesseling AC, Huebner R, Jean-Philippe P, Kabra SK, Kampmann B, Lewinsohn D, Li M, Lienhardt C, Mandalakas AM, Marais BJ, Menzies HJ, Montepiedra G, Mwansambo C, Oberhelman R, Palumbo P, Russek-Cohen E, Shapiro DE, Smith B, Soto-Castellares G, Starke JR, Swaminathan S, Wingfield C, Worrell C. 2012. Evaluation of tuberculosis diagnostics in children: 2. Methodological issues for conducting and reporting research evaluations of tuberculosis diagnostics for intrathoracic tuberculosis in children. Consensus from an expert panel. J. Infect. Dis. 205(Suppl 2):S209-S215.
9. Bates M, O'Grady J, Maeurer M, Tembo J, Chilukutu L, Chabala C, Kasonde R, Mulota P, Mzyece J, Chomba M, Mukonda L, Mumba M, Kapata N, Rachow A, Clowes P, Hoelscher M, Mwaba P, Zumla A. 2013. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study. Lancet Infect. Dis. 13:36-42.
10. Nicol MP, Workman L, Isaacs W, Munro J, Black F, Eley B, Boehme CC, Zemanay W, Zar HJ. 2011. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect. Dis. 11:819-824.
11. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. 2011. Interferon-gamma release assays and childhood tuberculosis: systematic review and meta-analysis. Int. J. Tuberc. Lung Dis. 15:1018-1032.
12. Graham SM, Ahmed T, Amanullah F, Browning R, Cardenas V, Casenghi M, Cuevas LE, Gale M, Gie RP, Grzemska M, Handelsman E, Hatherill M, Hesseling AC, Jean-Philippe P, Kampmann B, Kabra SK, Lienhardt C, Lighter-Fisher J, Madhi S, Makhene M, Marais BJ, McNeeley DF, Menzies H, Mitchell C, Modi S, Mofenson L, Musoke P, Nachman S, Powell C, Rigaud M, Rouzier V, Starke JR, Swaminathan S, Wingfield C. 2012. Evaluation of tuberculosis diagnostics in children: 1. Proposed clinical case definitions for classification of intrathoracic tuberculosis disease. Consensus from an expert panel. J. Infect. Dis. 205(Suppl 2):S199-S208.
13. Bergamini BM, Losi M, Vaienti F, D'Amico R, Meccugni B, Meacci M, De Giovanni D, Rumpianesi F, Fabbri LM, Balli F, Richeldi L. 2009. Performance of commercial blood tests for the diagnosis of latent tuberculosis infection in children and adolescents. Pediatrics 123:e419-e424. doi:10.1542/peds.2008-1722.
14. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. 2005. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm. Rep. 54:49-55.
15. Metcalfe JZ, Everett CK, Steingart KR, Cattamanchi A, Huang L, Hopewell PC, Pai M. 2011. Interferon-gamma release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis. J. Infect. Dis. 204(Suppl 4):S1120-S1129.
16. Elkington PT, Ugarte-Gil CA, Friedland JS. 2011. Matrix metalloproteinases in tuberculosis. Eur. Respir. J. 38:456-464.
17. Pfafflin A, Schleicher E. 2009. Inflammation markers in point-of-care testing (POCT). Anal. Bioanal. Chem. 393:1473-1480.
18. Mendonca VR, Luz NF, Santos NJ, Borges VM, Goncalves MS, Andrade BB, Barral-Netto M. 2012. Association between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria. Infect. Immun. 80:1445-1454.
19. Saukkonen K, Lakkisto P, Kaunisto MA, Varpula M, Voipio-Pulkki LM, Varpula T, Pettila V, Pulkki K. 2010. Heme oxygenase 1 polymorphisms and plasma concentrations in critically ill patients. Shock 34:558-564.
20. Brenchley JM, Douek DC. 2012. Microbial translocation across the GI tract. Annu. Rev. Immunol. 30:149-173.
21. Kroegel C, Antony VB. 1997. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur. Respir. J. 10 :2411-2418. (Pubitemid 27479569)
22. Matsuyama W, Hashiguchi T, Matsumuro K, Iwami F, Hirotsu Y, Kawabata M, Arimura K, Osame M. 2000. Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 162: 1120-1122.
23. Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. 2011. Immunological biomarkers of tuberculosis. Nat. Rev. Immunol. 11:343-354.
24. Elkington P, Shiomi T, Breen R, Nuttall RK, Ugarte-Gil CA, Walker NF, Saraiva L, Pedersen B, Mauri F, Lipman M, Edwards DR, Robertson BD, D'Armiento J, Friedland JS. 2011. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J. Clin. Invest. 121:1827-1833.
25. Clark IM, Swingler TE, Sampieri CL, Edwards DR. 2008. The regulation of matrix metalloproteinases and their inhibitors. Int. J. Biochem. Cell Biol. 40:1362-1378.
26. Sundararajan S, Babu S, Das SD. 2012. Comparison of localized versus systemic levels of matrix metalloproteinases (MMPs), its tissue inhibitors (TIMPs) and cytokines in tuberculous and non-tuberculous pleuritis patients. Hum. Immunol. 73:985-991.
27. Wilson D, Badri M, Maartens G. 2011. Performance of serum C-reactive protein as a screening test for smear-negative tuberculosis in an ambulatory high HIV prevalence population. PLoS One 6:e15248. doi:10.1371/journal.pone. 0015248.
28. Wallis RS, Wang C, Doherty TM, Onyebujoh P, Vahedi M, Laang H, Olesen O, Parida S, Zumla A. 2010. Biomarkers for tuberculosis disease activity, cure, and relapse. Lancet Infect. Dis. 10:68-69.
29. Agranoff D, Fernandez-Reyes D, Papadopoulos MC, Rojas SA, Herbster M, Loosemore A, Tarelli E, Sheldon J, Schwenk A, Pollok R, Rayner CF, Krishna S. 2006. Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum. Lancet 368:1012-1021. (Pubitemid 44353670)
30. Kumar A, Deshane JS, Crossman DK, Bolisetty S, Yan BS, Kramnik I, Agarwal A, Steyn AJ. 2008. Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon. J. Biol. Chem. 283:18032-18039.
31. Shiloh MU, Manzanillo P, Cox JS. 2008. Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection. Cell Host Microbe 3:323-330. (Pubitemid 351635997)
32. Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC. 2006. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12:1365-1371. (Pubitemid 44924494)
33. Sandler NG, Koh C, Roque A, Eccleston JL, Siegel RB, Demino M, Kleiner DE, Deeks SG, Liang TJ, Heller T, Douek DC. 2011. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology 141:1220-1230, 1230.e1-1230.e3. doi:10.1053/j.gastro.2011.06. 063.
34. Anuradha R, George PJ, Pavan Kumar N, Fay MP, Kumaraswami V, Nutman TB, Babu S. 2012. Circulating microbial products and acute phase proteins as markers of pathogenesis in lymphatic filarial disease. PLoS Pathog. 8:e1002749. doi:10.1371/journal.ppat.1002749.
35. George PJ, Anuradha R, Kumar NP, Kumaraswami V, Nutman TB, Babu S. 2012. Evidence of microbial translocation associated with perturbations in T cell and antigen-presenting cell homeostasis in hookworm infections. PLoS Negl Trop. Dis. 6:e1830. doi:10.1371/journal.pntd.0001830.
36. Mihret A, Bekele Y, Bobosha K, Kidd M, Aseffa A, Howe R, Walzl G. 2012. Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection. J. Infect. 66:357-365.
37. Riou C, Perez Peixoto B, Roberts L, Ronacher K, Walzl G, Manca C, Rustomjee R, Mthiyane T, Fallows D, Gray CM, Kaplan G. 2012. Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis. PLoS One 7:e36886. doi:10.1371/journal.pone.0036886.
38. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, Berezovskaya A, Rousset D, Reynes JM, Goldfeld AE. 2000. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J. Clin. Invest. 105:1317-1325. (Pubitemid 30266085)
39. Roberts T, Beyers N, Aguirre A, Walzl G. 2007. Immunosuppression during active tuberculosis is characterized by decreased interferon-gamma production and CD25 expression with elevated forkhead box P3, transforming growth factor-beta, and interleukin-4 mRNA levels. J. Infect. Dis. 195 : 870-878. (Pubitemid 46363933)
40. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. 1995. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J. Immunol. 154:465-473.
41. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-2247. (Pubitemid 23344885)
42. Cooper AM, Magram J, Ferrante J, Orme IM. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J. Exp. Med. 186:39-45. (Pubitemid 27304845)
43. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM. 2001. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345:1098-1104.
44. Fremond CM, Togbe D, Doz E, Rose S, Vasseur V, Maillet I, Jacobs M, Ryffel B, Quesniaux VF. 2007. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection. J. Immunol. 179:1178-1189.
45. + T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat. Immunol. 8:369-377.
46. Khader SA, Pearl JE, Sakamoto K, Gilmartin L, Bell GK, Jelley-Gibbs DM, Ghilardi N, deSauvage F, Cooper AM. 2005. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J. Immunol. 175:788-795. (Pubitemid 41094960)
47. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE, 3rd, Freedman VH, Kaplan G. 2001. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc. Natl. Acad. Sci. U. S. A. 98:5752-5757. (Pubitemid 32435714)
48. Manca C, Tsenova L, Freeman S, Barczak AK, Tovey M, Murray PJ, Barry C, Kaplan G. 2005. Hypervirulent M. tuberculosis W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway. J. Interferon Cytokine Res. 25:694-701. (Pubitemid 43010524)
49. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, Wilkinson KA, Banchereau R, Skinner J, Wilkinson RJ, Quinn C, Blankenship D, Dhawan R, Cush JJ, Mejias A, Ramilo O, Kon OM, Pascual V, Banchereau J, Chaussabel D, O'Garra A. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466:973-977.
50. Soares AP, Scriba TJ, Joseph S, Harbacheuski R, Murray RA, Gelderbloem SJ, Hawkridge A, Hussey GD, Maecker H, Kaplan G, Hanekom WA. 2008. Bacillus Calmette-Guerin vaccination of human newborns induces T cells with complex cytokine and phenotypic profiles. J. Immunol. 180:3569-3577.
51. Nahid P, Saukkonen J, Mac Kenzie W, Johnson JL, Phillips PJ, Andersen J, Bliven E, Belisle J, Boom H, Luetkemeyer A, Campbell T, Eisenach K, Hafner R, Lennox J, Makhene M, Swindells S, Villarino E, Weiner M, Benson C, Burman W. 2011. CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmap. Am. J. Respir. Crit. Care Med. 184:972-979.